Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

OptimizeRx Corp (OPRX)

$6.24 +0.48% NASDAQ: OPRX · 15-min delayed
  • WALTHAM, Massachusetts
  • Public · NASDAQ: OPRX
  • 105 employees
$95.9MMarket cap
$109.4MRevenue · FY2025
$5.1MNet income
105Employees
OPRXNASDAQ
1996IPO

About OptimizeRx Corp

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$109.4M
Net income
$5.1M
Total assets
$176.9M
Market cap
$95.9M
Gross margin
67.3%
Operating margin
10.7%
Net margin
4.7%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$109.4M
Cost of revenue
$35.8M
Gross profit
$73.6M
Operating expenses
$61.9M
Operating income
$11.7M
Income tax
$1.8M
Net income
$5.1M
EPS (basic)
$0.28
EPS (diluted)
$0.27

Balance sheet

Total assets
$176.9M
Current assets
$64.7M
Total liabilities
$48.6M
Current liabilities
$21.3M
Shareholders’ equity
$128.3M

Cash flow

Operating cash flow
$18.7M
Investing cash flow
$68.0K
Financing cash flow
-$8.8M
Net cash flow
$10.0M

Statements via Polygon.io (SEC filings)

NASDAQ: OPRX
$6.24 +0.48%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.54 $21.68

52-week range

Market cap
$95.9M
P/E ratio
23.1
EPS (diluted)
$0.27
Shares outstanding
15.4M
Open
Day range
Prev close
Volume
IPO date
Oct 22, 1996

OptimizeRx Corp (OPRX) Stock Price

  • Profitable — net income of $5.1M in FY2025.
  • Revenue grew 79% from FY2021 to FY2025.
  • Gross margin of 67.3%, net margin 4.7%.
  • Trading 71% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 23.1.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review OptimizeRx Corp.

Write a review
Newsroom

News about OptimizeRx Corp

News & sentiment via Polygon.io

FAQ

OptimizeRx Corp: frequently asked questions

Is OptimizeRx Corp an American company?

OptimizeRx Corp is a US-based company headquartered in Waltham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is OptimizeRx Corp headquartered?

OptimizeRx Corp is headquartered in Waltham, Massachusetts, United States.

Is OptimizeRx Corp publicly traded?

Yes — OptimizeRx Corp is a publicly traded company. Its stock trades under the ticker symbol OPRX on the NASDAQ.

What does OptimizeRx Corp do?

OptimizeRx Corp is an American Professional Services company in the Business & Financial Services sector.

Explore

Similar companies

Browse all →